SCHEMBL8586396

SCHEMBL8586396

O=C1Nc2ccccc2/C1=C\c1c[nH]c2ccc(C(=O)Nc3ccccc3)cc12

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NTRK1 P04629 7/20 0.60
RET P07949 3/20 0.60
PRKD3 O94806 2/20 0.60
ABL1 P00519 2/20 0.60
PDGFRB P09619 2/20 0.60
LTK P29376 2/20 0.60
KDR P35968 2/20 0.60
FLT3 P36888 2/20 0.60
CSNK1A1 P48729 2/20 0.60
CDK7 P50613 2/20 0.60
MAP2K1 Q02750 2/20 0.60
MST1R Q04912 2/20 0.60
NTRK3 Q16288 2/20 0.60
NTRK2 Q16620 2/20 0.60
AURKB Q96GD4 2/20 0.60
CLK4 Q9HAZ1 2/20 0.60
ALK Q9UM73 2/20 0.60
DAPK3 O43293 1/20 0.60
MAP4K4 O95819 1/20 0.60
LCK P06239 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8586401 1.00 NTRK1 (0.60) NTRK1RETPRKD3ABL1PDGFRB
SCHEMBL7874199 0.87 NTRK1 (0.68) NTRK1RETPRKD3ABL1PDGFRB
SCHEMBL8586092 0.85 NTRK1 (0.60) NTRK1RETPRKD3ABL1PDGFRB
SCHEMBL8586095 0.85 NTRK1 (0.60) NTRK1RETPRKD3ABL1PDGFRB
SCHEMBL8584643 0.85 NTRK1 (0.67) NTRK1RETPRKD3ABL1PDGFRB
SCHEMBL8584644 0.85 NTRK1 (0.67) NTRK1RETPRKD3ABL1PDGFRB
SCHEMBL8583945 0.84 NTRK1 (0.70) NTRK1RETPRKD3ABL1PDGFRB
SCHEMBL8583943 0.84 NTRK1 (0.70) NTRK1RETPRKD3ABL1PDGFRB
SCHEMBL8586376 0.82 NTRK1 (0.63) NTRK1RETPRKD3ABL1PDGFRB
SCHEMBL8586372 0.82 NTRK1 (0.63) NTRK1RETPRKD3ABL1PDGFRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5840745-A INHIBITING CELL PROLIFERATION, TUMOR GROWTH, METASTASIS, DEVELOPMENT OF ATHEROMATOUS PLAQUE AND RESTENOSIS, CONTROLLING ANGIOGENESIS, TREATING DIABETES, ENHANCING CANCER THERAPY PHARMACIA S. P. A. (IT) 1998-11-24 US claimed
EP-0752985-A1 HYDROSOLUBLE 3-ARYLIDENE-2-OXINDOLE DERIVATIVES AS TYROSINE KINASE INHIBITORS PHARMACIA & UPJOHN S.p.A. (IT) 1997-01-15 EP claimed
WO-1996022976-A1 HYDROSOLUBLE 3-ARYLIDENE-2-OXINDOLE DERIVATIVES AS TYROSINE KINASE INHIBITORS PHARMACIA S.P.A. (IT) 1996-08-01 WO claimed
US-5840745-A INHIBITING CELL PROLIFERATION, TUMOR GROWTH, METASTASIS, DEVELOPMENT OF ATHEROMATOUS PLAQUE AND RESTENOSIS, CONTROLLING ANGIOGENESIS, TREATING DIABETES, ENHANCING CANCER THERAPY PHARMACIA S. P. A. (IT) 1998-11-24 US disclosed
EP-0752985-A1 HYDROSOLUBLE 3-ARYLIDENE-2-OXINDOLE DERIVATIVES AS TYROSINE KINASE INHIBITORS PHARMACIA & UPJOHN S.p.A. (IT) 1997-01-15 EP disclosed
WO-1996022976-A1 HYDROSOLUBLE 3-ARYLIDENE-2-OXINDOLE DERIVATIVES AS TYROSINE KINASE INHIBITORS PHARMACIA S.P.A. (IT) 1996-08-01 WO disclosed